SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-19-005951
Filing Date
2019-03-04
Accepted
2019-03-04 10:33:23
Documents
3
Period of Report
2019-03-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K atrs-8k_20190301.htm 8-K 37167
2 EX-99.1 atrs-ex991_7.htm EX-99.1 16898
3 GRAPHIC gl0c0squgbz5000001.jpg GRAPHIC 17898
  Complete submission text file 0001564590-19-005951.txt   80412
Mailing Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628
Business Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628 609-359-3020
ANTARES PHARMA, INC. (Filer) CIK: 0001016169 (see all company filings)

IRS No.: 411350192 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32302 | Film No.: 19652290
SIC: 3841 Surgical & Medical Instruments & Apparatus
Assistant Director 10